The Prevalence and Phenotypic Features of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

    September 2016 in “ Human Reproduction ”
    Gurkan Bozdag, Sezcan Mumusoglu, Dila Zengin, Erdem Karabulut, Bulent O. Yildiz
    Image of study
    TLDR Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.
    The systematic review and meta-analysis investigated the prevalence and characteristics of polycystic ovary syndrome (PCOS) using different diagnostic criteria. The study included 24 articles and found that the prevalence of PCOS was 6% according to NIH criteria (18 trials), 10% according to Rotterdam criteria (15 trials), and 10% according to AE-PCOS Society criteria (10 trials). The prevalence of hirsutism was 13%, hyperandrogenemia 11%, polycystic ovaries 28%, and oligo-anovulation 15%. The study highlighted the impact of ethnic differences on PCOS features and the need for standardized definitions and methods for studying PCOS globally. It also pointed out the potential influence of obesity on prevalence rates and the importance of screening unselected populations to avoid referral bias. However, the study had limitations, including significant heterogeneity in prevalence across regions and the exclusion of non-English articles, which may have affected the results.
    Discuss this study in the Community →

    Research cited in this study

    9 / 9 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 3 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community C’est terrible - at my wits end

      in Female  448 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 6 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    6 / 1000+ results